NASDAQ
ORIC Pharmaceuticals, Inc. (ORIC) has a price/fcf ratio of -6.30x as of Monday, May 25, 2026. This represents a 11.12% decrease compared to its 12-month average of -5.67x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.